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INTRODUCTION 
The most used tool for measuring the insertion of a journal is an 
analysis of how often articles published in that journal were cited in 
other articles of the same or other journal, indexed in a particular 
da tabase, in a given time. Although imperfect, this method is used 
as an indicator of the global inclusion of a journal. Few years ago, 
the “Arquivos Brasileiros de Oftalmologia (ABO)” and the “Revista Bra-
sileira de Oftalmologia (RBO)” have become part of the Institute for 
Scientific Information (ISI) Web of Knowledge®, considered the most 
important database of scientific citations. The result of measurement 
of the citations made by ISI is published in the Journal Citation Re-
ports® (JCR) which contains several indicators, the best known being 
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Purpose: To compare clinical trials published in Brazilian journals of ophthalmology 
and in foreign journals of ophthalmology with respect to the number of citations 
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Trials (CONSORT) statement writing standards]. 
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Results: The citation counts were statistically significantly higher (P<0.001) in the 
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possible CONSORT items, the mean for the Foreign Group was 20.55 and for the 
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RESUMO
Objetivo: Comparar ensaios clínicos publicados em periódicos brasileiros de oftalmo-
logia e em periódicos estrangeiros de oftalmologia em relação ao número de citações 
e à qualidade da informação [através da aplicação do Consolidated Standards for 
Reporting Trials (CONSORT ) statement]. 
Métodos: A amostra desta revisão sistemática abrangeu os dois periódicos brasileiras 
de oftalmologia indexaoas no Science Citation Index Expanded (Grupo Brasileiro) e 
seis dos periódicos estrangeiros de oftalmologia com maior fator de impacto de acordo 
com o ISI (Grupo Estrangeiro). Todos os ensaios clínicos, publicados entre janeiro de 2009 
a dezembro de 2010, nos dois periódicos brasileiros e numa amostra aleatória 1:1 dos 
periódicos estrangeiros foram incluídos. O desfecho primário foi o número de citações 
até o final de 2011. A análise de subgrupos incluiu o idioma. O desfecho secundário 
incluiu a probabilidade de citação (citado ao menos uma vez versus não citado), e a 
presença ou ausência de indicadores da declaração CONSORT. 
Resultados: O número de citações foi significativamente maior (P<0,001) no Grupo 
Estrangeiro (10,50) em comparação com o Grupo Brasileiro (0,45). A probabilidade 
de citação foi estatisticamente superior (P<0,001) no Grupo Estrangeiro (20/20-
100%) comparado com o Grupo Brasileiro (8/20-41%). A análise de subgrupo sobre 
a influência da língua em artigos Brasileiros mostrou que o número de citações foi 
significativamente maior nos artigos publicados em Inglês (P<0,04). Dos 37 itens do 
CONSORT possíveis, a média para o Grupo Estrangeiro foi de 20,55 e para o Grupo 
Brasileiro foi 13,65 (P<0,003). 
Conclusão: O número de citações e a qualidade da redação dos ensaios clínicos em 
periódicos Brasileiros de oftalmologia ainda são baixos quando comparados com os 
periódicos estrangeiros de oftalmologia com mais alto fator de impacto.
Descritores: Ensaio clínico; Oftalmologia; Bases de dados de citações; Fator de impacto 
de revistas; Controle de qualidade
the Impact Factor®. The Impact Factor® of a journal in a given year 
is calculated based on the number of times articles published in the 
journal in the two previous years were cited in that year by all journals 
in that database(1). 
A clinical trial is a type of research study that tests how well new 
medical approaches work in people. These studies test new methods 
of screening, prevention, diagnosis, or treatment of a disease. Clini-
cal trials, when appropriately designed, conducted, and reported, 
represent the gold standard in evaluating healthcare interventions(2). 
The Consolidated Standards of Reporting Trials Group (CONSORT) 
statement provides a 25-item checklist for a minimum set of recom-
mendations for reporting the trial design, analysis, and results. It was 
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developed to assist authors in writing reports of clinical trials, editors 
and peer reviewers in reviewing manuscripts for publication, and 
readers in critically appraising published articles. It gives guidance 
for reporting all clinical trials, but focuses on the most common de-
sign type-individually randomized, two group, parallel trials, which 
accounts for over half of trials in the literature(3). 
The main purpose of this study is to compare clinical trials publi-
shed in Brazilians ophthalmology journals and in foreign ophthalmo-
logy journals with respect to the number of citations and the quality 
of reporting (by applying the CONSORT statement writing standards).
METHODS
This study was a systematic review. Originals clinical trials phase 
III or phase IV were identified by retrospective review of articles pu -
blished from January 2009 to December 2010 (2009/2010). Phase III 
trials compare the results of people taking a new treatment with the 
results of people taking the standard treatment. Phase IV trials are 
done using thousands of people after a treatment has been appro-
ved and marketed, to check for side effects that were not seen in the 
phase III trial. 
One group (Brazilian Group) included the two Brazilian journals 
of ophthalmology indexed at Science Citation Index Expanded (“Ar-
quivos Brasileiros de Oftalmologia” e “Revista Brasileira de Oftalmolo-
gia”), and the other group (Foreign Group) included six of the foreign 
journals of ophthalmology with highest Impact Factor® according 
ISI (Ophthalmology; American Journal of Ophthalmology; Archives 
of Ophthalmology; Investigative Ophthalmology and Vision Science; 
Journal of Cataract and Refractive Surgery; and British Journal of 
Oph thalmology)(4). 
The Brazilian group included all 20 clinical trials published in 
2009/2010(5-24). The Foreign group included a randomized (random 
order with a computer generated random number) sample of 20 
clinical trials among the 449 published in 2009/2010 [The Medline 
search strategies for clinical trial sought (publication type) was: 
“clinical trial”; or “clinical trial, phase III”; or “clinical trial, phase IV”; or 
“controlled clinical trial”](25-44). All articles were carefully scrutinized to 
confirm the study design. 
The primary outcome was the number of citations through the 
end of 2011(4). Most articles are rarely cited, if at all, during the same 
year in which they were published, but the citation count of the 2 
sub sequent years is representative (it forms the basis of estimating 
journal impact factors). Subgroup analysis included language.
The secondary outcome included likelihood of citation (cited at 
least once versus no citation), and presence or absence of CONSORT 
statement indicators(3). Although the CONSORT checklist has 25 items, 
our final grading scale had a maximum of 37 possible points, because 
there are general items divided in subparts. It was assigned 1 point 
per subpart.
Descriptive statistics were calculated. Continuous data were ex -
pres sed as mean values, standard deviation (SD) and ranges. Inde-
pendent sample t-test of equality of means was used to compare the 
2 groups. Analyses were conducted using PSPP statistical software. 
P values are 2-tailed. Statistical significance was considered at the 
0.05 level.
RESULTS
The citation counts were statistically significantly higher (P<0.001) 
in the Foreign Group (mean=10.50, SD=11.22, with a range from 1 to 
42) compared with the Brazilian Group (mean=0.45, SD=0.60, with a 
range from 0 to 2) (Figure 1). The likelihood citation was statistically 
significantly higher (P<0.001) in the Foreign Group (20/20 - 100%) 
compared with the Brazilian Group (8/20 - 40%). 
The subgroup analysis of the language influence in Brazilian arti-
cles showed that the citation counts were statistically significantly hi-
gher (P<0.04) in the papers published in English (mean=1.00, SD=0.82, 
with a range from 0 to 2) compared with the papers published in 
Portuguese (mean=0.31, SD=0.48, with a range from 0 to 1) (Figure 2).
Of 37 possible CONSORT items, the mean for the Foreign Group 
was 20.55 (54%), SD=5.07, with a range from 11 to 29 (30%-78%), 
and for the Brazilian Group was 13.65 (35%), SD=3.44, with a range 
from 8 to 21 (22%-57%). The difference was statistically significant 
(P<0.003) (Figure 3).
DISCUSSION
The results of this study demonstrated that the number of 
citations and quality of reporting of Brazilian journals of ophthal-
mology still are low when compared with the foreign journals of 
ophthalmology with higher Impact Factor. The situation is worse 
to the articles published in Portuguese. By analyzing the citation of 
articles according to the language in which they were published, it 
Figure 1. Citation counts of Foreign Group compared with the Brazilian Group. 
Figure 2. Subgroup analysis of the language influence in Brazilian articles.
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is possible notice that the number of citations of papers written in 
English is higher(1).
Citation analysis of ophthalmology articles has rarely been repor-
ted. The impact of a published article can be estimated by evaluating 
how frequently the study is cited in subsequent peer-reviewed 
publications(45). The number of times an article is cited over a given 
time period might indicates the level of importance attributed to its 
findings by research medical community(46). Researchers around the 
world rank their choices of journals for publication according to Im-
pact Factor®. The Coordination of Improvement of Higher Education 
Personnel (CAPES), which is the government agency in the Ministry 
of Education responsible for coordinating the post-graduation pro-
grams in Brazil, stratified the quality of the journals based exclusively 
from the ISI Impact Factor®(1). 
One of the actions to reach a higher number of citations on CTs 
may be to embrace principles of the CONSORT(47). The evidence-ba-
sed approach that has been used for CONSORT also served as a model 
for development of other reporting guidelines, such as for reporting 
systematic reviews and meta-analysis of studies evaluating interven-
tions (PRISMA)(48), and Strengthening the Reporting of Observational 
Studies in Epidemiology (STROBE)(49). However, as a potential drawback, 
a reporting guideline might encourage some authors to report ficti-
tiously the information suggested by the guidance rather than what 
was actually done. Readers, peer reviewers, and editors should vigi-
lantly guard against that potential drawback and refer, for example, 
to trial protocols, to information on trial registers, and to regulatory 
agency websites. Moreover, in some cases, the CONSORT can led to 
improvements in reporting but not in methodological conduct(50).
Some caveats of this study should be discussed. First, we com-
pared the national journals versus a sample of the most important 
foreign journals. However, the encouragement of our Brazilian 
scientific community toward the highest standards of study conduct 
and reporting is a realistic and important goal. Second, we can not 
generalize the results because we analyzed only CTs. But this study 
design, jointly with meta-analysis, is considered the gold standard for 
clinical research(51). Third, a citation does not guarantee the respect 
of the citing investigators. Occasionally a study may be cited only to 
be criticized or dismissed. Nevertheless, citation still means that the 
study is active in the scientific debate. Moreover, we should acknow-
ledge that number of citation does not necessarily translate into cli-
nical or scientific impact(40). Fourth, a presumable circumstance that 
may had contributed to the low citation of papers from the Brazilian 
journals was its relative low IF [in 2011, the IF of ABO was 0.326, and 
the IF of RBO was 0.129] in comparison to the group of the foreign 
journals (in 2011, the average of IF was 3.692), because there is a ten-
dency of authors to publish their best articles in journals with higher 
IF, perpetuating this situation(4). Finally, for the same reason above, 
Brazilians authors used to publish its best articles in foreign journals. 
Amazingly, in a paper applying the CONSORT and STROBE statements 
to evaluate the reporting quality of neovascular age-related macular 
degeneration studies the highest reporting scores were achieved by 
Brazilians articles published in foreign journals(48).
The boards of the Brazilians journals of ophthalmology are doing 
efforts to change this current unfavorable picture because they know 
the editorial scenario is competitive(1,52-55). Although the ABO and RBO 
have not yet officially adopted the CONSORT, neither the English 
lan guage, they encourage its use as well as other protocols such as 
STROBE and PRISMA. This attitude may contribute to the improve-
ment of Brazilian journals global insertion.
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